Canopy Homolog 2 contributes to liver oncogenesis by promoting unfolded protein response–dependent destabilization of tumor protein P53. Issue 6 (22nd February 2022)

• Record Type: Journal Article
• Authors: Hong, Feng; Lin, Ching Ying; Yan, Jingyue; Dong, Yizhou; Ouyang, Yuli; Kim, Doyeon; Zhang, Xiaoli; Liu, Bei; Sun, Shaoli; Gu, Wei; Li, Zihai
• Is Part Of: Hepatology. Volume 76:Issue 6(2022)
• Page Start: 1587
• Page End: 1601
• Publication Date: 2022-02-22
• Subjects: Heart -- Diseases -- Nursing -- Periodicals; Lungs -- Diseases -- Nursing -- Periodicals; Intensive care nursing -- Periodicals; Foie -- Maladies -- Périodiques; 616.362
• DOI: 10.1002/hep.32318
• Languages: English
• ISSNs: 0270-9139

Abstract

Abstract: Backgroud and Aims: Abnormalities in the tumor protein P53 ( p53 ) gene and overexpression of mouse double minute 2 homolog (MDM2), a negative regulator of p53, are commonly observed in cancers. p53 destabilization is regulated by endoplasmic reticulum (ER) stress and unfolded protein response (UPR) in cancer. However, the mechanisms remain enigmatic. Canopy homolog 2 (CNPY2) is a key UPR initiator that primarily involved in ER stress and is highly expressed in the liver, but its functional role in regulating liver carcinogenesis is poorly understood. Therefore, we aimed to investigate the role of CNPY2 in hepartocarcinogenesis through URP‐dependent p53 destabilization. Approach and Results: Here, we showed that CNPY2 expression is up‐regulated in HCC and negatively correlated with survival rate in liver cancer patients. Deletion of Cnpy2 obliterates diethylnitrosamine (DEN)‐induced HCC in mice. Mechanistic studies demonstrated that CNPY2 binds and prevents ribosome proteins from inhibiting MDM2 and enhances the UPR activity of protein kinase RNA‐like endoplasmic reticulum kinase and inositol‐requiring transmembrane kinase endoribonuclease‐1α, leading to p53 destabilization and cell‐cycle progression. In addition, transcriptome analyses uncovered that CNPY2 is also required for DEN‐induced expression of oncogenes, including c‐Jun and fibroblast growth factor 21. Intratumoral injection of nanoparticle‐based CRISPR single‐guide RNA/CRISPR‐associated protein 9 mRNA against Cnpy2 has antitumor effects in HCC. Conclusions: These findings demonstrate that CNPY2 is crucial for liver oncogenesis through UPR‐dependent repression of p53 and activation of oncogenes, providing insights into the design of a therapeutic target for HCC. Abstract : image